126 related articles for article (PubMed ID: 15802801)
1. Different effects of desipramine on bufuralol 1''-hydroxylation by rat and human CYP2D enzymes.
Isobe T; Hichiya H; Hanioka N; Yamamoto S; Shinoda S; Funae Y; Satoh T; Yamano S; Narimatsu S
Biol Pharm Bull; 2005 Apr; 28(4):634-40. PubMed ID: 15802801
[TBL] [Abstract][Full Text] [Related]
2. Catalytic specificity of CYP2D isoforms in rat and human.
Hiroi T; Chow T; Imaoka S; Funae Y
Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
[TBL] [Abstract][Full Text] [Related]
3. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
Murray M; Field SL
Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495
[TBL] [Abstract][Full Text] [Related]
5. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
Prueksaritanont T; Dwyer LM; Cribb AE
Biochem Pharmacol; 1995 Oct; 50(9):1521-5. PubMed ID: 7503805
[TBL] [Abstract][Full Text] [Related]
6. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.
Chow T; Imaoka S; Hiroi T; Funae Y
Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501
[TBL] [Abstract][Full Text] [Related]
7. The roles of amino acid residues at positions 43 and 45 in microsomal contents and enzymatic functions of rat CYP2D1 and CYP2D2.
Narimatsu S; Imoto K; Isobe T; Kiryu K; Naito S; Hichiya H; Funae Y; Hanioka N; Yamamoto S
Biochem Biophys Res Commun; 2004 Nov; 324(2):627-33. PubMed ID: 15474473
[TBL] [Abstract][Full Text] [Related]
8. Complementary DNA cloning and characterization of cytochrome P450 2D29 from Japanese monkey liver.
Hichiya H; Takemi C; Tsuzuki D; Yamamoto S; Asaoka K; Suzuki S; Satoh T; Shinoda S; Kataoka H; Narimatsu S
Biochem Pharmacol; 2002 Oct; 64(7):1101-10. PubMed ID: 12234613
[TBL] [Abstract][Full Text] [Related]
9. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
[TBL] [Abstract][Full Text] [Related]
10. Stereoselectivity in the oxidation of bufuralol, a chiral substrate, by human cytochrome P450s.
Narimatsu S; Takemi C; Kuramoto S; Tsuzuki D; Hichiya H; Tamagake K; Yamamoto S
Chirality; 2003 May; 15(4):333-9. PubMed ID: 12666241
[TBL] [Abstract][Full Text] [Related]
11. The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol.
Narimatsu S; Kazamori D; Masuda K; Katsu T; Funae Y; Naito S; Nakura H; Yamano S; Hanioka N
Biochem Pharmacol; 2009 Mar; 77(5):920-31. PubMed ID: 19059219
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of microsomal cytochromes P450 in rat liver by the tricyclic antidepressant drug desipramine and its primary oxidized metabolites.
McNeil CM; Murray M
Biochem Pharmacol; 1996 Jan; 51(1):15-20. PubMed ID: 8534263
[TBL] [Abstract][Full Text] [Related]
13. The 1'-hydroxylation of Rac-bufuralol by rat brain microsomes.
Coleman T; Spellman EF; Rostami-Hodjegan A; Lennard MS; Tucker GT
Drug Metab Dispos; 2000 Sep; 28(9):1094-9. PubMed ID: 10950855
[TBL] [Abstract][Full Text] [Related]
14. Cloning and functional expression of a novel marmoset cytochrome P450 2D enzyme, CYP2D30: comparison with the known marmoset CYP2D19.
Hichiya H; Kuramoto S; Yamamoto S; Shinoda S; Hanioka N; Narimatsu S; Asaoka K; Miyata A; Iwata S; Nomoto M; Satoh T; Kiryu K; Ueda N; Naito S; Tucker GT; Ellis SW
Biochem Pharmacol; 2004 Jul; 68(1):165-75. PubMed ID: 15183128
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol.
Narimatsu S; Arai T; Masubuchi Y; Horie T; Hosokawa M; Ueno K; Kataoka H; Yamamoto S; Ishikawa T; Cho AK
Biol Pharm Bull; 2001 Sep; 24(9):988-94. PubMed ID: 11558582
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective metabolism of bufuralol racemate and enantiomers in human liver microsomes.
Narimatsu S; Takemi C; Tsuzuki D; Kataoka H; Yamamoto S; Shimada N; Suzuki S; Satoh T; Meyer UA; Gonzalez FJ
J Pharmacol Exp Ther; 2002 Oct; 303(1):172-8. PubMed ID: 12235248
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression.
Schulz-Utermoehl T; Bennett AJ; Ellis SW; Tucker GT; Boobis AR; Edwards RJ
Pharmacogenetics; 1999 Jun; 9(3):357-66. PubMed ID: 10471068
[TBL] [Abstract][Full Text] [Related]
18. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6.
Mankowski DC
Drug Metab Dispos; 1999 Sep; 27(9):1024-8. PubMed ID: 10460802
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes.
Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T
Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070
[TBL] [Abstract][Full Text] [Related]
20. Regioselective hydroxylation of an antiarrhythmic drug, propafenone, mediated by rat liver cytochrome P450 2D2 differs from that catalyzed by human P450 2D6.
Uehara S; Murayama N; Yamazaki H; Suemizu H
Xenobiotica; 2019 Nov; 49(11):1323-1331. PubMed ID: 30596462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]